Nadolol
Overview
Nadolol is a non-selective beta-adrenergic blocker used in the management of hypertension and angina pectoris. It decreases heart rate, cardiac output, and blood pressure to improve cardiovascular function.
API suppliers (5)
Suppliers of Nadolol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 5 suppliers.
1 of 5 holds a GMP certificate on record in the EU or UK registers
- FERMION OYFinland1 active DMF GMP on record
- SIGNA SA DE CV1 active DMF
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
- SYNCHEM CHEMICALS PRIVATE LTD
EU CEP holders (3)
Companies holding a valid EU Certificate of Suitability (CEP) for Nadolol, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Nadolol? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.